BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Pharmova Ltd: key numbers
- Share price
- ₹964.65
- Market cap
- ₹15,365 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 43.6×Sector 43.8×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Pharmova Ltd
All →Jubilant Pharmova Results Update
Q2 revenue rose 21% to Rs 2,370 Cr, but EBITDA fell 27% and PAT dropped to Rs 31 Cr. SPECT supply gaps and remediation costs compressed margins.
Jubilant Pharmova Q2 FY27 Results: Net Profit ₹31 Cr, Down 74.1% YoY
Jubilant Pharmova Ltd reported revenue from operations of ₹2,370 Cr (+20.5% YoY) and net profit of ₹31 Cr (-74.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹31 Cr · -74.1% YoY
Jubilant Pharmova Business Update
Jubilant Pharmova's subsidiary Jubilant Therapeutics will present preliminary Phase 1 clinical data for JBI-802 at the 68th ASH meeting. A company event on December 14, 2026 will discuss the data.
Jubilant Pharmova Debt & Borrowing: ₹800 Cr
Jubilant Pharmova allotted 80,000 unsecured NCDs worth Rs 800 Crore on a private placement basis. The 8.50% debentures mature in November 2028.
- Value
- ₹800.0 Cr
- Execution
- 3 years (maturity 05 November 2028)
Jubilant Pharmova Board Meeting Date
Jubilant Pharmova has scheduled a board meeting for November 13, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing is a Regulation 29 advance intimation only.
Jubilant Pharmova Annual General Meeting
Jubilant Pharmova Ltd has issued a Postal Ballot Notice seeking shareholder approval for the private placement issuance of Non-Convertible Debentures.
Other business update announcements
All →Tata Communications Business Update
Tata Communications disclosed a press release on a Frost & Sullivan 2026 Company of the Year recognition for large-enterprise communications services. It is an award announcement with no financial or transactional event.
Amwill Health Care Business Update
Amwill Health Care signed an exclusive private-label supply agreement with a Thai pharma manufacturer. The five-year deal covers hair colour imports for India, with no upfront payment.
- Execution
- 5 years
Kothari Industrial Corporation Business Update
Kothari Industrial intimated plans to relocate its KICKERS showroom from Indore. The destination city, premises and timing remain undecided.
Vishnu Chemicals Business Update
Vishnu Chemicals' Parwada plant in Visakhapatnam resumed full operations on 13 November 2026. The earlier temporary stoppage was for forward integration and new capital projects.
Sharp Chucks And Machines Business Update
SCML entered a PPA with Spark Grid Project B for captive renewable energy, acquiring 26% equity in the SPV. No contract value or capacity is disclosed.
DEE Development Engineers Business Update
DEE Development Engineers reported its October 2026 order book with a closing position of $2,586.43 million. No single new award is announced in this periodic update.